Transarterial Chemoembolization (TACE)

Transarterial chemoembolization (TACE) is the administration of a chemotherapeutic agent through an artery directly to a cancerous tumor in the liver, followed by the embolization of the blood vessels feeding the cancerous tumor, causing interruption of blood. This is a palliative treatment for patients not eligible for surgery. However, a portion of viable cancer cells may remain and new feeding vessels can grow from surrounding tissue. Therefore, it is necessary to undergo repeated sessions at 6- to 8-week intervals to eliminate the remaining cancer cells.

  • Patients with a progressive large-sized tumor or multiple tumors.
  • When surgery is not possible due to insufficient post-operative functional liver.
  • The need to pre-operatively decrease the tumor size for patients awaiting liver surgery or transplantation.
  • Palliative treatment.
  • Patients with poor liver disease assessment.
  • Patients with portal vein thrombosis.
  • Extrahepatic metastasis affecting the survival rates of patients.
  • Extensive liver involvement of the cancerous tumor more than 50%.
  • Patients with a history of severe contrast allergy.
  • Bruising or hematoma at the puncture site.
  • Nausea, vomiting, and low fever occur about 40-50% of the time and usually during the first 2-3 days. These symptoms normally go away on their own after 1-2 weeks.
  • Ascites, liver abscess and bloodstream infection, which are rare.
After you are discharged, it is recommended that you stay at a hotel close to the hospital for at least one day for convenience in traveling to hospital if any complications arise after the procedure.

Related conditions

Doctors Related

Related Centers

Diagnostic Center

Learn more

Urology Center

Learn more

Related Packages

Rating score NaN of 10, based on 0 vote(s)

Related Health Blogs